Dakota Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-781
Closed -$304K 693
2025
Q2
$304K Buy
781
+190
+32% +$76.4K 0.01% 615
2025
Q1
$257K Buy
+591
New +$237K 0.01% 656
2024
Q4
Sell
-1,068
Closed -$555K 767
2024
Q3
$555K Buy
1,068
+122
+13% +$65.2K 0.01% 484
2024
Q2
$513K Buy
946
+16
+2% +$8.46K 0.01% 504
2024
Q1
$482K Buy
930
+306
+49% +$152K 0.01% 507
2023
Q4
$294K Sell
624
-29
-4% -$13.4K 0.01% 525
2023
Q3
$284K Sell
653
-208
-24% -$94.3K 0.01% 502
2023
Q2
$383K Sell
861
-6
-0.7% -$2.77K 0.02% 433
2023
Q1
$399K Buy
867
+150
+21% +$71.4K 0.03% 408
2022
Q4
$368K Buy
717
+271
+61% +$138K 0.03% 409
2022
Q3
$203K Buy
+446
New +$213K 0.02% 502

Other funds holding ELV

Dakota Wealth Management's ELV Position: Q3 2025 in Review

Dakota Wealth Management sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 781 shares — an estimated $304K sold.

Dakota Wealth Management first reported a position in ELV in Q3 2022 and held it in 11 quarters. The position peaked at $555K in Q3 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Dakota Wealth Management reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Dakota Wealth Management sold 781 Elevance Health shares in Q3 2025, an estimated $304K.
  • Dakota Wealth Management first reported a position in Elevance Health in Q3 2022 and held it in 11 quarters.
  • Dakota Wealth Management's Elevance Health position peaked at $555K in Q3 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Dakota Wealth Management's 13F filing for Q3 2025, filed 10 Nov 2025.